Combretastatin A4
98%,LC
- Product Code: 55035
CAS:
117048-59-6
| Molecular Weight: | 316.35 g./mol | Molecular Formula: | C₁₈H₂₀O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD03453309 | |
| Melting Point: | 84.5-85.5°C | Boiling Point: | 490.3°C |
| Density: | 1.184 g/cm3 | Storage Condition: | -20°C |
Product Description:
Combretastatin A4 is primarily used in medical research and treatment, particularly in the field of oncology. It functions as a vascular disrupting agent, targeting and collapsing the blood vessels that supply tumors. This action starves the tumor of oxygen and nutrients, leading to its shrinkage. It is often studied in combination with other cancer therapies, such as chemotherapy or radiation, to enhance their effectiveness. Additionally, it is being explored for its potential in treating age-related macular degeneration by inhibiting abnormal blood vessel growth in the eye. Its unique mechanism makes it a promising candidate for further development in cancer and other vascular-related diseases.
Product Specification:
| Test | Specification |
|---|---|
| Purity | 98-100 |
| MELTING POINT | 112-118 |
| APPEARANCE | WHITE TO OFF-WHITE CRYSTAL POWDER |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $31.56 |
+
-
|
| 0.025 | 10-20 days | $47.76 |
+
-
|
| 0.100 | 10-20 days | $150.33 |
+
-
|
| 0.500 | 10-20 days | $531.57 |
+
-
|
| 1.000 | 10-20 days | $925.27 |
+
-
|
Combretastatin A4
Combretastatin A4 is primarily used in medical research and treatment, particularly in the field of oncology. It functions as a vascular disrupting agent, targeting and collapsing the blood vessels that supply tumors. This action starves the tumor of oxygen and nutrients, leading to its shrinkage. It is often studied in combination with other cancer therapies, such as chemotherapy or radiation, to enhance their effectiveness. Additionally, it is being explored for its potential in treating age-related macular degeneration by inhibiting abnormal blood vessel growth in the eye. Its unique mechanism makes it a promising candidate for further development in cancer and other vascular-related diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :